The period from newborn to 28 days after birth is defined as the neonatal period. During this period, the blood coagulation system in infants is undergoing continuous improvements and maturation.
VIII. The coagulation factors are lower in concentration neonates than in adults. [1] [2] [3] [4] [5] In addition, neonates have a different balance of haemostasis than adults or infants. It is in balance, but this balance is more labile, so in situations of an ill neonate, the risk of bleeding is increased. It is necessary to monitor the blood coagulation functions of newborns. provide specific data about clot quality or stability.
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The thromboelastograph (TEG) haemostasis analyser system can objectively reflect the blood clotting, fibrinogen/fibrin/platelet interactions, and the formation, development and dissolution of thrombus processes in the body. [8] [9] [10] [11] [12] The TEG is intended to provide a complete analysis to help determine the right blood product or therapy at the right time to manage the patient's risk for haemorrhage or thrombosis. In addition, the TEG has played an important role in the diagnosis and management of coagulation disorders in paediatric patients and neonates.
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While the coagulation status of neonates is different from adults, the reference range of coagulation-related indexes is also significantly different from adults. [16] [17] [18] Therefore, it is necessary to establish a biological reference range related to coagulation for the neonatal period, which can help clinicians become acquainted with the coagulation status of newborns over time. However, there is no published reference range for TEG parameters in the neonatal period thus far. Data about the standard range of TEG parameters for newborns are limited. 16, 19, 20 In addition, because of the differences in research designs, reagents and methods, the establishment of ref-
erence ranges is more complicated.
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The aim of our study was to establish the reference range of TEG parameters for healthy full-term infants in the neonatal period.
The results of this study have been significant in assessing the coagulation status and diagnosing the blood coagulation disorder in neonates. This study is conducive to the clinical diagnosis and management of neonatal coagulation-related diseases.
| MATERIAL S AND ME THODS

| Study population and design
A retrospective study was conducted on neonates born at the Wuhan
Children's Hospital, Tongji Medical College, Huazhong University of Science and Technology, from January 2016 to December 2017. A total of 371 full-term infants in the neonatal period were recruited as study subjects. This study has been approved by the Hospital Ethics Committee of our hospital. Because the participants were neonates, this study obtained the informed consent signed by their guardians.
All the neonates were selected based on gestational age ≥37 weeks, appropriate birthweight (2.5-3.9 kg), and not given 
| Biochemical analysis
We collected 2 mL peripheral blood with 0.109 mol/L sodium cit- Both the TEG tests and routine coagulation tests were performed within 2 hours after blood collection.
| Statistical analysis
For each group of TEG parameters, we used the 2.5th and 97.5th
percentiles to establish a reference range, according to the NCCRS guide. 25 The distribution of the group was evaluated by Q-Q plots and Shapiro-Wilk tests, and almost all tests showed significant deviations from normality. Therefore, nonparametric methods were used for analysis; McNemar's test was used for the analysis between the reference range provided by our study and manufacturers. The Mann-Whitney U test was used among two groups. The Kruskal-Wallis one-way ANOVA test (k samples) was used among groups, and the Spearman correlation was used for the correlation analysis among the parameters. All statistical analyses were performed using spss 22 software. All P-values were two-tailed values. For all tests, a P-value <0.05 indicated statistical significance.
| RE SULTS
| Characteristics of the study population, TEG reference interval of neonates, coagulation test reference interval of neonates
The study population consists of 371 full-term (≥37 weeks of gestation) healthy infants. Demographic and clinical data and the parameters of the standard TEG and coagulation tests are presented in Table 1 .
| Comparing the differences of TEG parameters reference range provided by this study and manufacturers in evaluating neonatal coagulation
The McNemar test was used for the analysis between the reference ranges provided by our study and manufacturers. The results presented in Table 2 show that there were significant differences in R,
Angle, K and MA values between the two methods.
| The effects of patient characteristics on TEG values
To analyse the influences of patient characteristics on TEG values, nonparametric methods were utilized for TEG values and gestational age, birthweight and age at examination. According to Spearman's correlation coefficient, there were significant negative correlations between age and K value (ρ = −0.601, P < 0.001) and significant positive correlations between age and Angle (ρ = 0.592, P < 0.001), age and MA (ρ = 0.614, P < 0.001), age and LY30 (ρ = 0.288, P = 0.012),
and MA and birthweight (ρ = 0.130, P = 0.012). The Mann-Whitney U test was used to analyse the TEG results of different genders and modes of delivery in newborns. Except for the R value, there
were no significant differences in the Angle, K, MA and LY30 parameters according to gender and mode of delivery. The R value of females was higher than that of males (P = 0.001), and the R value of caesarean section was higher than that of spontaneous delivery (P = 0.044).
| TEG parameters for different age groups
Newborns were divided into 3 groups according to age as follows: However, the correlations between the K value and coagulation test parameters were negative. In addition, the R value was only positively correlated with the APTT test. Please refer to Table 4 for all correlation results.
| D ISCUSS I ON
The normal reference range of neonatal coagulation-related indicators is significantly different from that of adults. 4, 5, 19, 26 The level of coagulation factors in neonates is only 50% of that in adults, and the level of these factors does not reach the adult level until an infant is 6 months old. 19 In addition, thrombin and its precursors in newborns are also at low level, which eventually leads to an increase in APTT and PT and a decrease in Fib. It has been reported that neonatal However, the usefulness of the TEG is limited in paediatric populations, especially neonates, mainly owing to the lack of reference ranges and standardization. Currently, the normal reference range of neonatal TEG parameters is mostly based on the biological reference range of adults provided by reagent manufacturers. 30 Approximately 8.5% of the healthy neonates were diagnosed with coagulation abnormalities according to the reference range provided by the manufacturers for TEG determination. 31 The results may mislead clinicians in the diagnosis and treatment and cause adverse events.
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To acquaint clinicians with the coagulation status of neonates over time and to give intervention and treatment actively in neonates, it is necessary to determine the TEG biological reference range for newborns. 32 Reference range for newborns would also help to avoid misdiagnosis and to reduce neonatal mortality. Results showed that the younger the neonate is, the higher the risk of bleeding, and healthy newborns showed a positive correlation with the speed of starting coagulation, which was consistent with previous TA B L E 3 Thromboelastograph (TEG) parameters for different age groups Note: The McNemar test was used for the analysis between the reference ranges determined in our study and provided by manufacturers. R (s), K (s), Angle (α), maximum amplitude (MA, mm) and lysis at 30 min (LY30, %). Abbreviation(s): A/A, abnormal data evaluated by both methods; A/N, abnormal data evaluated by this study, normal data evaluated by manufacturers; N/A, normal data evaluated by this study, abnormal data evaluated by manufacturers; N/N, normal data evaluated by both methods; TEG, thromboelastograph. **P < 0.01.
TA B L E 2 Comparing the differences in the reference ranges of TEG parameters determined in this study and provided by manufacturers in evaluating neonatal coagulation reports. 15, 20, 33 In addition, the R value was more prolonged in newborns delivered by caesarean section, indicating a probable higher risk of bleeding by caesarean section. According to the statistical results,
we found that the R value was also related to gender, the R value was more prolonged in girls and they may be at higher risk of bleeding.
We analysed the correlation between TEG parameters and blood coagulation parameters and platelet counts, which was discussed in the results section. The R value was only positively correlated with the APTT test. The TEG test in this study used kaolin; thus, it initiated coagulation activation through the intrinsic pathway, which is the same pathway as the APTT test. However, our research has some limitations. Due to the difficulty in collecting whole blood samples from newborns and recruiting healthy newborns, the number of healthy patients in this study was relatively small. The number of neonates in delivery mode, gender and age was different. There were different amounts of neonates in each group, with more patients with ages between 8 and 28 days than in other age groups. All the above parameters should be further studied.
| CON CLUS ION
It is necessary to consider the differences in the normal values of the blood coagulation-related tests between neonates and adults when 
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